Universe Pharmaceuticals income statement data for the quarter ended Mar 2026. This income statement covers 12 quarters of results from Sep 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Mar2021 | Sep2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional items | ||||||||||||
| Shares Outstanding | 177,790.00 | 177,790.00 | 210,913.00 | 210,913.00 | 241,684.00 | 241,684.00 | 241,679.00 | 241,679.00 | 241,679.00 | 241,679.00 | 455,871.00 | 455,871.00 |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 177,790.00 | 177,790.00 | 210,909.00 | 210,909.00 | 241,679.00 | 241,679.00 | 241,679.00 | 241,679.00 | 241,679.00 | 241,679.00 | 455,871.00 | 455,871.00 |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 177,790.00 | 241,684.00 | 241,684.00 | 243,077.00 | 455,871.00 |